Published in Gastroenterology on September 01, 1987
Factor V Leiden related Budd-Chiari syndrome. Gut (2001) 1.17
Paroxysmal nocturnal hemoglobinuria with no evidence of hemolysis presenting as Budd-Chiari syndrome. Dig Dis Sci (2000) 0.85
Budd-Chiari syndrome: a case with a combination of hepatic vein and superior vena cava occlusion. World J Gastroenterol (2005) 0.80
Delayed duodenal obstruction after intramural hematoma in a patient with paroxysmal nocturnal hemoglobinuria: A case report. Int J Surg Case Rep (2014) 0.79
Small hepatic veins Budd-Chiari syndrome. J Thromb Thrombolysis (2014) 0.75
Recurrent small bowel ischemia in a patient with paroxysmal nocturnal hemoglobinuria. Nat Rev Gastroenterol Hepatol (2010) 0.75
The first case of paroxysmal nocturnal hemoglobinuria and Budd-Chiari syndrome treated with complement inhibitor eculizumab in Korea. Blood Res (2017) 0.75
Cholangitis and paroxysmal nocturnal hemoglobinuria. Dig Dis Sci (1997) 0.75
Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med (1993) 4.43
Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy. Ann Intern Med (1997) 3.49
Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology (2000) 3.16
Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a controlled study. N Engl J Med (1981) 3.13
Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct. N Engl J Med (2001) 2.95
Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. J Infect Dis (1995) 2.89
Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy. Gastroenterology (2001) 2.75
Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men. Hepatology (1999) 2.63
Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg (1991) 2.46
Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. French Society of Haematology. Lancet (1996) 2.41
Fulminant and subfulminant liver failure: definitions and causes. Semin Liver Dis (1986) 2.39
Recombinant human alpha-interferon in patients with chronic non-A, non-B hepatitis: a multicenter randomized controlled trial from France. Hepatology (1991) 2.38
Recent portal or mesenteric venous thrombosis: increased recognition and frequent recanalization on anticoagulant therapy. Hepatology (2000) 2.34
Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen. N Engl J Med (1985) 2.29
Propranolol--a medical treatment for portal hypertension? Lancet (1980) 2.27
Early administration of vapreotide for variceal bleeding in patients with cirrhosis. N Engl J Med (2001) 2.25
Hepatocellular carcinoma occurring in nonfibrotic liver: epidemiologic and histopathologic analysis of 80 French cases. Hepatology (2000) 2.21
Fatal exacerbation of chronic hepatitis B induced by recombinant alpha-interferon. Lancet (1991) 2.14
Idarubicin-loaded beads for chemoembolisation of hepatocellular carcinoma: results of the IDASPHERE phase I trial. Aliment Pharmacol Ther (2014) 2.11
Portal hypertension, size of esophageal varices, and risk of gastrointestinal bleeding in alcoholic cirrhosis. Gastroenterology (1980) 2.02
The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*. J Viral Hepat (2011) 2.00
Mechanism of phenobarbital-induced hypercholeresis in the rat. Am J Physiol (1970) 1.99
Ectopic varices in portal hypertension. Clin Gastroenterol (1985) 1.90
Acute hepatic necrosis and fulminant hepatic failure. Gut (1973) 1.87
The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study. Hepatology (2001) 1.87
Second generation (RIBA) test in diagnosis of chronic hepatitis C. Lancet (1991) 1.84
Characteristics of patients with dual infection by hepatitis B and C viruses. J Hepatol (1998) 1.84
Relationship between alcohol and tobacco dependencies among alcoholics who smoke. Addiction (1995) 1.81
Management of focal nodular hyperplasia and hepatocellular adenoma in young women: a series of 41 patients with clinical, radiological, and pathological correlations. Hepatology (1995) 1.78
Etiology of portal vein thrombosis in adults. A prospective evaluation of primary myeloproliferative disorders. Gastroenterology (1988) 1.76
Primary myeloproliferative disorder and hepatic vein thrombosis. A prospective study of erythroid colony formation in vitro in 20 patients with Budd-Chiari syndrome. Ann Intern Med (1985) 1.75
Hepatitis C virus in dermatology. A review. Arch Dermatol (1995) 1.71
A randomized trial of prednisolone in patients with severe alcoholic hepatitis. N Engl J Med (1992) 1.71
Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C. Hepatology (1998) 1.69
Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology (1994) 1.69
Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C. J Hepatol (2001) 1.68
Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients. Gut (2002) 1.68
Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation. Gut (2005) 1.65
Focal nodular hyperplasia of the liver in men: is presentation the same in men and women? Gut (2002) 1.65
Immune complex type glomerulonephritis in cirrhosis of the liver. Am J Pathol (1975) 1.63
Liver adenomatosis. An entity distinct from liver adenoma? Gastroenterology (1985) 1.62
Assessment of the benefits and risks of percutaneous biopsy before surgical resection of hepatocellular carcinoma. J Hepatol (2001) 1.61
Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology (1986) 1.59
Interferon resistance of hepatitis C virus genotype 1b: relationship to nonstructural 5A gene quasispecies mutations. J Virol (1998) 1.59
Emergency liver transplantation for fulminant hepatitis. Ann Intern Med (1987) 1.56
Insulin resistance and geographical origin: major predictors of liver fibrosis and response to peginterferon and ribavirin in HCV-4. Gut (2009) 1.56
Common bile duct stricture as a late complication of upper abdominal radiotherapy. J Hepatol (1994) 1.56
A randomized controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a final report. Hepatology (1984) 1.56
Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: a French survey of 6,664 patients. The Study Group for the Prevalence and the Epidemiology of Hepatitis C Virus. Hepatology (1997) 1.55
Expression of complement-regulatory proteins in normal and UW-preserved human liver. Gastroenterology (1994) 1.54
Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes. Ann Intern Med (1995) 1.53
Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in health care workers (HCWs): guidelines for prevention of transmission of HBV and HCV from HCW to patients. J Clin Virol (2003) 1.53
Standardization of hepatitis C virus RNA quantification. Hepatology (2000) 1.52
Pulmonary hypertension complicating portal hypertension: prevalence and relation to splanchnic hemodynamics. Gastroenterology (1991) 1.52
Sclerosing cholangitis induced by formaldehyde solution injected into the biliary tree of rats. Arch Surg (1990) 1.52
Cigarette smoking and hepatic lesions in patients with chronic hepatitis C. Hepatology (2001) 1.51
Hepatitis C virus infection in patients with overt B-cell non-Hodgkin's lymphoma in a French center. Blood (1999) 1.51
Association of hepatic vein obstruction and coeliac disease in North African subjects. J Hepatol (1994) 1.51
Hepatitis after intravenous buprenorphine misuse in heroin addicts. J Hepatol (2001) 1.51
Randomized controlled trial of adenine arabinoside 5'-monophosphate in chronic active hepatitis B: comparison of the efficacy in heterosexual and homosexual patients. Hepatology (1989) 1.50
A controlled study of therapeutic portacaval shunt in alcoholic cirrhosis. Lancet (1976) 1.49
Oral contraceptive use and focal nodular hyperplasia of the liver. Gastroenterology (2000) 1.49
Effect of inhibitors of sodium transport on bile formation in the rabbit. Am J Physiol (1970) 1.49
Combined liver transplantation and pancreatoduodenectomy for irresectable hilar bile duct carcinoma. Br J Surg (1995) 1.48
Peliosis hepatis in recipients of renal transplants. Gut (1978) 1.48
Propranolol in prevention of recurrent gastrointestinal bleeding in cirrhotic patients. Lancet (1981) 1.47
Protein F. A novel F(ab)-binding factor, present in normal liver, and largely released in the digestive tract during hepatitis. J Immunol (1990) 1.47
Role of hepatitis C virus in lymphoproliferative disorders after liver transplantation. Hepatology (1999) 1.45
Influence of hepatitis G virus infection on the severity of liver disease and response to interferon-alpha in patients with chronic hepatitis C. Ann Intern Med (1997) 1.44
Autoimmune chronic hepatitis exacerbated by alpha-interferon. Ann Intern Med (1992) 1.44
The effect of propranolol on portal hypertension in patients with cirrhosis: a hemodynamic study. Hepatology (1982) 1.44
Transvenous liver biopsy: an experience based on 1000 hepatic tissue samplings with this procedure. Gastroenterology (1982) 1.43
Is the response to recombinant alpha interferon related to the presence of antibodies to hepatitis C virus in patients with chronic non-A, non-B hepatitis? J Hepatol (1990) 1.43
Focal neurological signs in hepatic encephalopathy in cirrhotic patients: an underestimated entity? Am J Gastroenterol (2001) 1.42
Relative risk of hepatocellular carcinoma in HBsAg positive vs alcoholic cirrhosis. A cross-sectional study. Liver (1990) 1.40
Impact of smoking on histological liver lesions in chronic hepatitis C. Gut (2003) 1.40
Evolution of bacterial susceptibility to antibiotics during a six-year period in a haematology unit. J Hosp Infect (1995) 1.39
[Code of professional ethics in clinical research]. Gastroenterol Clin Biol (2001) 1.39
Exacerbation of multiple sclerosis after the administration of recombinant human interferon alfa. JAMA (1989) 1.38
What strategy should be used for diagnosis of hepatitis C virus infection in clinical laboratories? Hepatology (1998) 1.36
Outcome of Budd-Chiari syndrome: a multivariate analysis of factors related to survival including surgical portosystemic shunting. Hepatology (1999) 1.35